Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Soluble Immune Checkpoint Molecules in Intra-abdominal Infection: Association With Disease Severity and Mortality

NCT07689266 is registered in ClinicalTrials.gov with Istanbul Training and Research Hospital as lead sponsor.

NCT NCT07689266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07689266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Soluble Immune Checkpoint Molecules in Intra-abdominal Infection: Association With Disease Severity and Mortality
Lead sponsor
Istanbul Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2023
Completion date
August 1, 2025
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intra abdominal infections